Skip to main content

naltrexone hydrochloride; oxycodone

Generic: NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE·Brand: TROXYCA ER

naltrexone hydrochloride; oxycodone: developed by 1 company · 1 FDA decision.

naltrexone hydrochloride; oxycodone evidence translation

What we can confirm

1 FDA record

What it means

Source-backed records connect naltrexone hydrochloride; oxycodone to PFE; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

How could naltrexone hydrochloride; oxycodone → PFE affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

Development Pipeline (2)
CompanyPhase
PFIZER INC (PFE)Approved
PFIZER INC (PFE)Approved
FDA Decisions1 records
Approval(PFE)FDA ↗
NDA207621Type 3 - New Dosage Form and Type 4 - New CombinationStandardOralCapsule, Extended Release

Frequently asked questions

Who is developing naltrexone hydrochloride; oxycodone?

naltrexone hydrochloride; oxycodone is being developed by PFIZER INC.

What is naltrexone hydrochloride; oxycodone's latest FDA decision?

The most recent tracked FDA decision for naltrexone hydrochloride; oxycodone is Approval, dated August 19, 2016.